APA

Martin-Facklam M., Rengelshausen J., Tayrouz Y., Ketabi-Kiyanvash N., Lindenmaier H., Schneider V., Bergk V. & Haefeli W. E. (20050513). Dose individualisation in patients with renal insufficiency: does drug labelling support optimal management?. : European journal of clinical pharmacology.

Chicago

Martin-Facklam Meret, Rengelshausen Jens, Tayrouz Yorki, Ketabi-Kiyanvash Nahal, Lindenmaier Heike, Schneider Verena, Bergk Verena and Haefeli Walter E. 20050513. Dose individualisation in patients with renal insufficiency: does drug labelling support optimal management?. : European journal of clinical pharmacology.

Harvard

Martin-Facklam M., Rengelshausen J., Tayrouz Y., Ketabi-Kiyanvash N., Lindenmaier H., Schneider V., Bergk V. and Haefeli W. E. (20050513). Dose individualisation in patients with renal insufficiency: does drug labelling support optimal management?. : European journal of clinical pharmacology.

MLA

Martin-Facklam Meret, Rengelshausen Jens, Tayrouz Yorki, Ketabi-Kiyanvash Nahal, Lindenmaier Heike, Schneider Verena, Bergk Verena and Haefeli Walter E. Dose individualisation in patients with renal insufficiency: does drug labelling support optimal management?. : European journal of clinical pharmacology. 20050513.